Inventor · disambiguated record
Richard E. Showalter
Also filed as: SHOWALTER RICHARD · SHOWALTER RICHARD E
9 granted patents·2 pending applications·22 citations·filing 1999–2023
83Inventor score
Top patents by PatentIndex Score
11 records- 0176US9789170B2Arginine deiminase with reduced cross-reactivity toward ADI-PEG 20 antibodies for cancer treatmentPOLARIS GROUP·Filed 2015·Granted Oct 17, 2017·4 cites·27 claims
- 0270US6316603B1Modifications of the VEGF receptor-2 protein and methods of useAGOURON PHARMA·Filed 1999·Granted Nov 13, 2001·15 cites·10 claims
- 0362US2024084282A1Modified arginine deiminasesPOLARIS GROUP·Filed 2023·Application pending·0 cites
- 0458US11235037B2Arginine deiminase with reduced cross-reactivity toward ADI - PEG 20 antibodies for cancer treatmentPOLARIS GROUP·Filed 2014·Granted Feb 1, 2022·0 cites·20 claims
- 0558US2022105160A1Arginine deiminase with reduced cross-reactivity toward adi - peg 20 antibodies for cancer treatmentPOLARIS GROUP·Filed 2021·Application pending·0 cites
- 0657US10463721B2Engineered chimeric pegylated ADI and methods of useTDW GROUP·Filed 2015·Granted Nov 5, 2019·1 cites·23 claims
- 0756US6794146B2Modifications of the VEGF receptor-2 protein and methods of useAGOURON PHARMA·Filed 2001·Granted Sep 21, 2004·0 cites·2 claims
- 0850US6849721B2Modifications of the VEGF receptor-2 protein and methods of useAGOURON PHARMA·Filed 2001·Granted Feb 1, 2005·1 cites·7 claims
- 0950US6784285B1Modifications of the VEGF Receptor-2 Protein and methods of useAGOURON PHARMA·Filed 2000·Granted Aug 31, 2004·1 cites·4 claims
- 1048US12344645B2Protein conjugatesPOLARIS GROUP GRAND CAYMAN·Filed 2018·Granted Jul 1, 2025·0 cites·20 claims
- 1141US6753416B2Modifications of the VEGF receptor-2 protein and methods of useAGOURON PHARMA·Filed 2001·Granted Jun 22, 2004·0 cites·2 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →